Cardiovascular Exercise Drives Neuroprotection in a Mouse Model of Spinocerebellar Ataxia 1 Via Rescue of Aberrant Splicing
Annals of Neurology · 2026
DOI: 10.1002/ana.78282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Isabel Soto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Neuroprotection, Physical Conditioning, Animal, RNA Splicing. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
Spinocerebellar ataxia 1 (SCA1) is a fatal hereditary neurodegenerative disorder with no approved therapies, and gene‐targeting strategies have thus far failed in clinical trials. Exercise remains the only intervention shown to provide clinical benefit in patients with spinocerebellar ataxias (SCAs), yet the underlying mechanisms remain poorly understood.
Methods
Using the Atxn1 154Q/2Q knock‐in mouse model, we implemented a prolonged voluntary wheel‐running paradigm from 4 to 16 weeks of age. Mice were then phenotyped using motor and cognitive behavioral assays. Following euthanasia, cerebellar tissue was harvested for histological analysis and unbiased transcriptomics.
Results
Unrestricted exercise rescued motor ataxia but not degeneration in this SCA1 mouse model at the ages in this study. Transcriptional profiling of cerebellar tissue separated wild‐type (WT) sedentary and exercise mice by differential gene expression, but in SCA1 mice the most pronounced changes occurred at the level of RNA splicing, particularly in ion channel modules. Exercise led to a significant rescue of splicing events in SCA1 mice, with minimal impact on gene expression changes. Further, both exercised SCA1 and WT mice exhibited splicing patterns more similar to each other than their sedentary counterparts.
Interpretation
Together with emerging evidence in other SCAs, our findings confirm aberrant splicing as a central driver of SCA pathophysiology and identify splicing‐regulated networks as actionable therapeutic targets. The observed benefits in SCA1 mice suggest that correcting mis‐spliced ion channels may be a viable strategy for disease modification across SCAs and related neurodegenerative disorders. ANN NEUROL 2026;100:850–866
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
- Department of Biological Sciences and the RNA Institute, College of Arts & Sciences, University at Albany, State University of New York, Albany, NY, USA.
- Program in Biomedical Sciences, University of Michigan, Ann Arbor, MI, USA.
ORCID-Profile: Benjamin D Carr, Sharan R Srinivasan
Förderung
- NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Soto, I., Bonomo, M., Nelthrope, B. S., Carr, B. D., Palmer, E., Sierra, M., Erturk, I., Peppercorn, D., Cox, E., Vasconcellos, T. K., Paulson, H. L., Shorrock, H. K., & Srinivasan, S. R. (2026). Cardiovascular Exercise Drives Neuroprotection in a Mouse Model of Spinocerebellar Ataxia 1 Via Rescue of Aberrant Splicing. Annals of Neurology. https://doi.org/10.1002/ana.78282
Vancouver
Soto I, Bonomo M, Nelthrope BS, Carr BD, Palmer E, Sierra M, et al. Cardiovascular Exercise Drives Neuroprotection in a Mouse Model of Spinocerebellar Ataxia 1 Via Rescue of Aberrant Splicing. Annals of Neurology. 2026. doi:10.1002/ana.78282
BibTeX
@article{Soto2026,
author = {Soto, Isabel and Bonomo, Michael and Nelthrope, Brianna S and Carr, Benjamin D and Palmer, Emma and Sierra, Mariana and Erturk, Ilkim and Peppercorn, David and Cox, Eleonor and Vasconcellos, Tiare K and Paulson, Henry L and Shorrock, Hannah K and Srinivasan, Sharan R},
title = {Cardiovascular Exercise Drives Neuroprotection in a Mouse Model of Spinocerebellar Ataxia 1 Via Rescue of Aberrant Splicing},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78282}
}
EUVIMED